GeoVax Labs Inc (GOVX):製薬・医療:M&Aディール及び事業提携情報

【英語タイトル】GeoVax Labs Inc (GOVX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalDataが出版した調査資料(DATA904C10012)・商品コード:DATA904C10012
・発行会社(調査会社):GlobalData
・発行日:2018年11月
・ページ数:60
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥26,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥79,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000を加算
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
GeoVax Labs Inc (GeoVax) develops human vaccines for diseases caused by human immunodeficiency virus (HIV), cancer and other infectious diseases using Modified Vaccinia Ankara Virus-Like Particle (MVA-VLP) vaccine platform. The company’s vaccine development programs focus on HIV, Zika virus and hemorrhagic fever viruses (Ebola, Marburg, Lassa fever) and for cancer immunotherapy. Its advanced vaccines under development act against the clade B subtype of the HIV virus and clade C subtype. GeoVax developed its proprietary vaccine technology in collaboration with the U.S. National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC) and Emory University. GeoVax is headquartered in Smyrna, Georgia, the US.

GeoVax Labs Inc (GOVX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
GeoVax Labs Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
GeoVax Labs Inc, Medical Devices Deals, 2012 to YTD 2018 10
GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
GeoVax Labs and PharmaJet Enter into Partnership 13
Geovax Labs and Emory University Enter into Partnership 14
GeoVax Labs Enters into Agreement with CaroGen 15
GeoVax Labs Enters into Agreement with Vaxeal 16
GeoVax Labs Enters into Agreement with Scripps Research Institute and Institute of Human Virology 17
GeoVax Labs Enters into Partnership with American Gene Technologies 18
GeoVax Labs Research Agreement with Georgia State University Research Foundation 19
GeoVax Labs Enters into Research Agreement with Burnet Institute 20
GeoVax Labs Enters into Co-Development Agreement with ViaMune 21
GeoVax Labs Enters into Research Agreement with Centers for Disease Control and Prevention 22
GeoVax Labs Enters into R&D Agreement with USAMRIID 23
GeoVax Labs Enters into Research Agreement with University of Georgia 24
GeoVax Labs Enters into Research Agreement with University of Pittsburgh 25
GeoVax Labs Enters into Research Agreement with National Institute of Allergy and Infectious Diseases 26
Licensing Agreements 27
GeoVax Labs Enters into Licensing Agreement with Valneva 27
Equity Offering 28
GeoVax Labs to Issue Up to 66,666,666 Series D Convertible Preferred Stock 28
GeoVax Labs Issues 1,000 Shares in Private Placement of Series D Preferred Stock 29
GeoVax Labs Raise Funds through in Public Offering of Shares up on Exercise of Warrants 30
GeoVax Labs Raises USD6 Million in Private Placement 31
GeoVax Labs Completes Private Placement Of Shares For US$1.6 Million 32
GeoVax Completes Private Placement Of Series A Convertible Preferred Stock For US$2.2 Million 33
GeoVax Completes Second Tranche Of Private Placement Of Units For US$0.25 Million 34
GeoVax Labs Inc – Key Competitors 35
GeoVax Labs Inc – Key Employees 36
GeoVax Labs Inc – Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Recent Developments 38
Financial Announcements 38
Aug 07, 2018: GeoVax reports 2018 second quarter financial results and provides corporate update 38
May 03, 2018: GeoVax Reports 2018 First Quarter Financial Results and Development Program Updates 40
Mar 23, 2018: GeoVax Announces 2017 Year-End Financial Results 42
Nov 09, 2017: GeoVax Reports 2017 Third Quarter Financial Results and Development Program Updates 43
Aug 07, 2017: GeoVax Reports 2017 Second Quarter Financial Results Results and Provides Corporate Update 45
May 08, 2017: GeoVax Reports 2017 First Quarter Financial Results and Development Program Updates 47
Mar 24, 2017: GeoVax Reports 2016 Year-End Financial Results 48
Corporate Communications 49
Aug 14, 2018: GeoVax names David Dodd as Chairman, President and Chief Executive Officer 49
Product News 50
10/09/2017: GeoVax Chief Scientific Officer to Deliver Two Talks at World Vaccine Congress 50
08/30/2017: GeoVax Presents Preliminary Data for Cancer Vaccine 51
04/03/2017: GeoVax Awarded $658,000 NIH Grant for its HIV Vaccine Program 52
01/16/2018: GeoVax Publishes Ebola Vaccine Study Results in Nature’s Scientific Reports 53
Clinical Trials 54
Jan 23, 2017: GeoVax Announces Initiation of HIV Human Clinical Trial 54
Other Significant Developments 55
Mar 28, 2018: GeoVax Provides Vaccine Development Update 55
Mar 27, 2017: GeoVax Reports on Vaccine Development Progress 58
Appendix 60
Methodology 60
About GlobalData 60
Contact Us 60
Disclaimer 60

List of Tables
GeoVax Labs Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
GeoVax Labs Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
GeoVax Labs Inc, Deals By Therapy Area, 2012 to YTD 2018 9
GeoVax Labs Inc, Medical Devices Deals, 2012 to YTD 2018 10
GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
GeoVax Labs and PharmaJet Enter into Partnership 13
Geovax Labs and Emory University Enter into Partnership 14
GeoVax Labs Enters into Agreement with CaroGen 15
GeoVax Labs Enters into Agreement with Vaxeal 16
GeoVax Labs Enters into Agreement with Scripps Research Institute and Institute of Human Virology 17
GeoVax Labs Enters into Partnership with American Gene Technologies 18
GeoVax Labs Research Agreement with Georgia State University Research Foundation 19
GeoVax Labs Enters into Research Agreement with Burnet Institute 20
GeoVax Labs Enters into Co-Development Agreement with ViaMune 21
GeoVax Labs Enters into Research Agreement with Centers for Disease Control and Prevention 22
GeoVax Labs Enters into R&D Agreement with USAMRIID 23
GeoVax Labs Enters into Research Agreement with University of Georgia 24
GeoVax Labs Enters into Research Agreement with University of Pittsburgh 25
GeoVax Labs Enters into Research Agreement with National Institute of Allergy and Infectious Diseases 26
GeoVax Labs Enters into Licensing Agreement with Valneva 27
GeoVax Labs to Issue Up to 66,666,666 Series D Convertible Preferred Stock 28
GeoVax Labs Issues 1,000 Shares in Private Placement of Series D Preferred Stock 29
GeoVax Labs Raise Funds through in Public Offering of Shares up on Exercise of Warrants 30
GeoVax Labs Raises USD6 Million in Private Placement 31
GeoVax Labs Completes Private Placement Of Shares For US$1.6 Million 32
GeoVax Completes Private Placement Of Series A Convertible Preferred Stock For US$2.2 Million 33
GeoVax Completes Second Tranche Of Private Placement Of Units For US$0.25 Million 34
GeoVax Labs Inc, Key Competitors 35
GeoVax Labs Inc, Key Employees 36
GeoVax Labs Inc, Subsidiaries 37

List of Figures
GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
GeoVax Labs Inc, Medical Devices Deals, 2012 to YTD 2018 10

★調査レポート[GeoVax Labs Inc (GOVX):製薬・医療:M&Aディール及び事業提携情報] (コード:DATA904C10012)販売に関する免責事項を必ずご確認ください。
★調査レポート[GeoVax Labs Inc (GOVX):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆